T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.45B |
| 2 |
Pinterest
PINS
|
+$1.89B |
| 3 |
T-Mobile US
TMUS
|
+$1.89B |
| 4 |
Zoom
ZM
|
+$1.77B |
| 5 |
UiPath
PATH
|
+$1.71B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$3.66B |
| 2 |
Caterpillar
CAT
|
+$1.32B |
| 3 |
Netflix
NFLX
|
+$1.18B |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$1.15B |
| 5 |
Micron Technology
MU
|
+$1.07B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.71% |
| 2 | Healthcare | 16.11% |
| 3 | Consumer Discretionary | 15.3% |
| 4 | Communication Services | 13.46% |
| 5 | Financials | 12.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
Cerence
CRNC
$396M
| $3.09M | ﹤0.01% |
28,933
-2,663
| -8% | -$262K |
|
1602
ImmunityBio
IBRX
$7.97B
| $3.07M | ﹤0.01% |
215,008
+12,070
| +6% | +$199K |
|
1603
Macy's
M
$6.24B
| $3.07M | ﹤0.01% |
161,749
-5,400
| -3% | -$95.9K |
|
1604
New York Times
NYT
$10.5B
| $3.02M | ﹤0.01% |
69,238
+312
| +0.5% | +$13.9K |
|
|
CIT
1605
DELISTED
CIT Group Inc.
CIT
| $3M | ﹤0.01% |
58,127
+405
| +0.7% | +$21.3K |
|
1606
Carter's
CRI
$1.43B
| $3M | ﹤0.01% |
29,040
+104
| +0.4% | +$10.6K |
|
|
LHCG
1607
DELISTED
LHC Group LLC
LHCG
| $3M | ﹤0.01% |
14,955
-273
| -2% | -$54.7K |
|
1608
LXP Industrial Trust
LXP
$3.58B
| $2.98M | ﹤0.01% |
49,860
+2,254
| +5% | +$137K |
|
1609
Arrow Electronics
ARW
$10.8B
| $2.98M | ﹤0.01% |
26,155
-1,226
| -4% | -$144K |
|
1610
Fox Factory Holding Corp
FOXF
$889M
| $2.97M | ﹤0.01% |
19,084
-204
| -1% | -$30.3K |
|
1611
HealthEquity
HQY
$8.8B
| $2.94M | ﹤0.01% |
36,579
-4,031
| -10% | -$307K |
|
1612
Murphy Oil
MUR
$5.04B
| $2.93M | ﹤0.01% |
125,961
-13,956
| -10% | -$285K |
|
|
NEE.PRO
1613
DELISTED
NextEra Energy, Inc. 4.872% Corporate Units
NEE.PRO
| $2.93M | ﹤0.01% |
52,425
-12,500
| -19% | -$715K |
|
1614
Thor Industries
THO
$4.11B
| $2.92M | ﹤0.01% |
25,810
-1,293
| -5% | -$164K |
|
|
UHT
1615
Universal Health Realty Income Trust
UHT
$573M
| $2.91M | ﹤0.01% |
47,315
-16,580
| -26% | -$1.12M |
|
1616
Encompass Health
EHC
$12.2B
| $2.91M | ﹤0.01% |
46,830
-3,558
| -7% | -$237K |
|
1617
Upbound Group
UPBD
$1.14B
| $2.89M | ﹤0.01% |
54,535
+2,632
| +5% | +$153K |
|
|
LNW
1618
DELISTED
Light & Wonder
LNW
| $2.89M | ﹤0.01% |
37,330
-1,783
| -5% | -$109K |
|
1619
Jefferies Financial Group
JEF
$12.8B
| $2.87M | ﹤0.01% |
87,792
+4,932
| +6% | +$150K |
|
|
ADVWW
1620
DELISTED
Advantage Solutions Warrant
ADVWW
| $2.86M | ﹤0.01% |
1,147,912
+963
| +0.1% | +$3.17K |
|
|
WRI
1621
DELISTED
Weingarten Realty Investors
WRI
| $2.85M | ﹤0.01% |
88,743
-18,104
| -17% | -$570K |
|
1622
Cullen/Frost Bankers
CFR
$10.5B
| $2.83M | ﹤0.01% |
25,237
-1,525
| -6% | -$178K |
|
1623
Helmerich & Payne
HP
$4.43B
| $2.83M | ﹤0.01% |
86,642
-18,570
| -18% | -$546K |
|
1624
Canadian Pacific Kansas City
CP
$82.8B
| $2.81M | ﹤0.01% |
36,549
+839
| +2% | +$65K |
|
1625
nVent Electric
NVT
$28.1B
| $2.8M | ﹤0.01% |
89,494
-15,133
| -14% | -$466K |
|
Similar funds
T. Rowe Price Associates's Q2 2021 Portfolio in Review
As of Q2 2021, T. Rowe Price Associates held 3,000 positions worth $1.08T, up 8% from $999B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q2 2021 filing shows 159 new, 1,164 increased, 1,499 reduced and 84 closed positions. Its largest new stake was UiPath: 23,377,090 shares worth $1.52B. The largest sale was Alibaba, an estimated $3.66B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2021 buy was UiPath: 23,377,090 shares worth $1.52B.
- T. Rowe Price Associates added most to Microsoft in Q2 2021, an estimated $3.45B increase.
- T. Rowe Price Associates's biggest Q2 2021 reduction was Alibaba, cutting an estimated $3.66B.
- T. Rowe Price Associates fully exited Pershing Square Tontine Holdings, Ltd. in Q2 2021, selling an estimated $145M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $1.08T portfolio in Q2 2021.
- T. Rowe Price Associates opened 159 new positions and closed 84 in Q2 2021.
- T. Rowe Price Associates's portfolio value rose 8% quarter-over-quarter to $1.08T.
Based on T. Rowe Price Associates's 13F filing for Q2 2021, filed 16 Aug 2021.